I keep floating up and so it's like really hard
A phase I safety study in healthy adults confirmed that subcutaneous MOTS-c injections at doses up to 10 mg produced no serious adverse events, with a pharmacokinetic profile supporting once-daily or every-other-day dosing [3]
July 2024: Roche reported early clinical data for CT-996, its once-daily oral GLP-1 receptor agonist, showing clinically meaningful weight loss after four weeks and supporting further development in obesity and type 2 diabetes
AST, aspartate transaminase
Those are the treatments discussed above, which are nonsurgical, and are mostly focused on lasers, microneedling, injections, medications, and supplements